Comparative toxicity of citalopram and the newer antidepressants after overdose.
about
A review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdoseVentricular dysrhythmias associated with poisoning and drug overdose: a 10-year review of statewide poison control center data from California.Comparative Toxicity of Tapentadol and Tramadol Utilizing Data Reported to the National Poison Data System.Clinical course and toxicokinetic data following isolated citalopram overdose in an infant.Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study.Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose.Tolerability and safety of fluvoxamine and other antidepressants.Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases.5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT).Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest.A comparison of venlafaxine and SSRIs in deliberate self-poisoningAntidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults - a Swedish nationwide study.Lack of significant toxicity after mirtazapine overdose: a five-year review of cases admitted to a regional toxicology unit.Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management.Predictive factors for generalized seizures after deliberate citalopram overdoseMirtazapine overdose is unlikely to cause major toxicity.Citalopram and cardiac toxicity.Metabolic and toxicological considerations for obsessive-compulsive disorder drug therapy.Seizures after single-agent overdose with pharmaceutical drugs: analysis of cases reported to a poison center.Treatment of depression with selective serotonin inhibitors: the role of fluvoxamine.CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation.QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.Risk of QT/QTc prolongation among newer non-SSRI antidepressants.ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram.Desvenlafaxine overdose and the occurrence of serotonin toxicity, seizures and cardiovascular effects.Serotonin syndrome: pills, thrills and shoulder aches.What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology.Self-poisonings with tricyclic antidepressants and selective serotonin reuptake inhibitors in Tehran, Iran.Single-agent duloxetine ingestions.Fatal cardiotoxicity induced by venlafaxine overdosage.Poisoning with rivastigmine.Palpitations and Asthenia Associated with Venlafaxine in a CYP2D6 Poor Metabolizer and CYP2C19 Intermediate Metabolizer.Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children.Contributory and incidental blood concentrations in deaths involving citalopram.[Intoxication with psychotropic drugs].A retrospective analysis of antidepressant poisonings in the emergency department: 11-year experience.
P2860
Q24606269-6DAE644E-B475-440C-8239-02CB544C5647Q30883223-C6A1F032-F716-48B4-8C29-0C4CAF6139F7Q30993522-48C65A3E-9E94-4D8E-93E9-1B43A237E23AQ31036699-4F8BBD7E-3641-4693-8D17-45FF6E767E0CQ33632295-C988C3E2-7656-4615-988F-1BEA29D5B11DQ33820358-178FFCB9-1204-45CB-82E3-0EED1A429D29Q33995120-BD624189-B083-4CE5-B07A-F88AE12D05EDQ36024615-AAF74908-4391-43DF-B858-A8EF5194221DQ36514263-7C0F7CBC-8719-4735-91EA-FB3E8287626CQ36548724-89E5F34F-4DB1-4F90-86D0-652FB8B4732FQ36549123-78A21CE6-485F-4E88-8ADA-878741828F9AQ36706808-3F3B27D4-58A4-4851-B46C-C4D4074A4331Q36759259-713791C7-B158-42D9-B418-CBFADE9136CAQ36814510-87CC6561-55C3-44F5-A3A8-393AA227F76AQ37175817-65806197-E186-4A18-97DD-F4AC5B073B9EQ37489869-91E766AC-6537-4255-BE4C-3A15003DC6FEQ38045165-F01E76C1-8E36-4C8D-BAE4-5F606534F62EQ38092129-4063817D-42AF-47F1-9B9F-2C1B34D313BCQ38213129-5961D4EF-530B-4707-AD3C-F92A5A1B70B5Q38221223-0FBDEEB8-3D3A-44A1-BC5F-482E4A97D611Q38239777-5505F04C-CE67-4B8E-8C29-13BC1CD808A5Q38244346-46BD9F70-290C-4F4B-8389-85432D1165B4Q38247487-C4805332-192D-474D-8F2F-0C745015D69EQ39447754-FDAB003B-E98B-4E99-8DC0-BDAD01F954FAQ40583867-7023864B-A0F7-45A3-9660-68DCE0CF8D01Q42253661-4534EFEB-8118-464C-BE03-EEF47B634058Q42955459-347ED903-2432-4E7B-B0E0-233E19F5DE97Q43239655-233EFEF9-10B1-448F-BDBD-4C0227661FDEQ43446891-44E849B5-62BA-46A5-BC27-E0139615B198Q46685299-42819E83-530E-4C69-BDEF-D1CFB67921DAQ46914325-6982A4F1-1664-4991-A2CD-1CBF908E361DQ47151234-0D3103F6-C7B4-4E4D-B300-96F0EA335232Q47899567-D67F0E1B-4C6D-43F8-88F2-647978E69575Q48548810-D543F3FA-51B1-428A-87AA-E1990CC88333Q52313894-6D78BCA5-F26C-42B3-9BDF-E83D6B04C84EQ53820040-353A6B5F-9446-427C-AAD0-E225681AF95E
P2860
Comparative toxicity of citalopram and the newer antidepressants after overdose.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Comparative toxicity of citalopram and the newer antidepressants after overdose.
@ast
Comparative toxicity of citalopram and the newer antidepressants after overdose.
@en
type
label
Comparative toxicity of citalopram and the newer antidepressants after overdose.
@ast
Comparative toxicity of citalopram and the newer antidepressants after overdose.
@en
prefLabel
Comparative toxicity of citalopram and the newer antidepressants after overdose.
@ast
Comparative toxicity of citalopram and the newer antidepressants after overdose.
@en
P2093
P2860
P356
P1476
Comparative toxicity of citalopram and the newer antidepressants after overdose
@en
P2093
P2860
P356
10.1081/CLT-120028747
P577
2004-01-01T00:00:00Z